Search

Carla J. Myers

Examiner (ID: 5220, Phone: (571)272-0747 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1655, 1682, 1643, 1609, 1621, 1654, 1807, 1634, 1644
Total Applications
2312
Issued Applications
1000
Pending Applications
336
Abandoned Applications
987

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19318712 [patent_doc_number] => 20240240255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/021748 [patent_app_country] => US [patent_app_date] => 2021-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021748 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/021748
BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF Aug 16, 2021 Pending
Array ( [id] => 18243560 [patent_doc_number] => 20230075871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => METHOD FOR DETERMINING RADIATION EXPOSURE WITH SENSITIVE AND SPECIFIC GENE EXPRESSION SIGNATURES [patent_app_type] => utility [patent_app_number] => 17/402550 [patent_app_country] => US [patent_app_date] => 2021-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402550 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/402550
METHOD FOR DETERMINING RADIATION EXPOSURE WITH SENSITIVE AND SPECIFIC GENE EXPRESSION SIGNATURES Aug 14, 2021 Abandoned
Array ( [id] => 17370393 [patent_doc_number] => 20220025445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => GENOTYPING OF POLYPLOIDS [patent_app_type] => utility [patent_app_number] => 17/402037 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/402037
GENOTYPING OF POLYPLOIDS Aug 12, 2021 Pending
Array ( [id] => 17705036 [patent_doc_number] => 20220205042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries [patent_app_type] => utility [patent_app_number] => 17/401643 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401643 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401643
Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries Aug 12, 2021 Pending
Array ( [id] => 18701650 [patent_doc_number] => 11788151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => C-RAF mutants that confer resistance to RAF inhibitors [patent_app_type] => utility [patent_app_number] => 17/399563 [patent_app_country] => US [patent_app_date] => 2021-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 16308 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399563 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/399563
C-RAF mutants that confer resistance to RAF inhibitors Aug 10, 2021 Issued
Array ( [id] => 18583256 [patent_doc_number] => 20230265516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => SINGLE NUCLEOTIDE POLYMORPHISMS AND TREATMENT OF INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/040976 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040976 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/040976
SINGLE NUCLEOTIDE POLYMORPHISMS AND TREATMENT OF INFLAMMATORY CONDITIONS Aug 5, 2021 Pending
Array ( [id] => 18709612 [patent_doc_number] => 20230332233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => USE OF microRNA (miRNA) MARKER IN PREPARATION OF PRODUCT FOR EVALUATING THERAPEUTIC EFFECT OF OLANZAPINE IN TREATMENT OF SCHIZOPHRENIA (SZ) AND KIT [patent_app_type] => utility [patent_app_number] => 18/025639 [patent_app_country] => US [patent_app_date] => 2021-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025639 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025639
Use of microRNA (miRNA) marker in preparation of product for evaluating therapeutic effect of olanzapine in treatment of schizophrenia (SZ) and kit Aug 3, 2021 Issued
Array ( [id] => 18676789 [patent_doc_number] => 20230314419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => TARGET MEASUREMENT METHOD, TARGET MEASUREMENT DEVICE, TARGET MEASUREMENT APPARATUS, AND TARGET MEASUREMENT KIT [patent_app_type] => utility [patent_app_number] => 18/023249 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023249 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023249
TARGET MEASUREMENT METHOD, TARGET MEASUREMENT DEVICE, TARGET MEASUREMENT APPARATUS, AND TARGET MEASUREMENT KIT Jul 29, 2021 Pending
Array ( [id] => 17228984 [patent_doc_number] => 20210355540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => ASSESSMENT OF RISK OF ANEUPLOIDY [patent_app_type] => utility [patent_app_number] => 17/390620 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13009 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390620 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/390620
ASSESSMENT OF RISK OF ANEUPLOIDY Jul 29, 2021 Abandoned
Array ( [id] => 17657509 [patent_doc_number] => 20220177974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => GENETIC SIGNATURES TO PREDICT PROSTATE CANCER METASTASIS AND IDENTIFY TUMOR AGGRESSIVENESS [patent_app_type] => utility [patent_app_number] => 17/390674 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/390674
GENETIC SIGNATURES TO PREDICT PROSTATE CANCER METASTASIS AND IDENTIFY TUMOR AGGRESSIVENESS Jul 29, 2021 Abandoned
Array ( [id] => 19051318 [patent_doc_number] => 20240093287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => METHODS AND COMPOSITIONS FOR REDUCING INDEX HOPPING [patent_app_type] => utility [patent_app_number] => 18/018401 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22167 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018401 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018401
METHODS AND COMPOSITIONS FOR REDUCING INDEX HOPPING Jul 29, 2021 Abandoned
Array ( [id] => 17688237 [patent_doc_number] => 20220195529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY [patent_app_type] => utility [patent_app_number] => 17/386088 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386088 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/386088
ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY Jul 26, 2021 Abandoned
Array ( [id] => 17414412 [patent_doc_number] => 20220049316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF BREAST CANCER METASTASIS [patent_app_type] => utility [patent_app_number] => 17/385568 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385568 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/385568
Method for the diagnosis, prognosis and treatment of breast cancer metastasis Jul 25, 2021 Issued
Array ( [id] => 17214892 [patent_doc_number] => 20210348229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => COMBINATORIAL DNA SCREENING [patent_app_type] => utility [patent_app_number] => 17/383273 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383273 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/383273
Combinatorial DNA screening Jul 21, 2021 Issued
Array ( [id] => 17357168 [patent_doc_number] => 20220017964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => Cornulin (CRNN) Variants And Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/378900 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/378900
Cornulin (CRNN) Variants And Uses Thereof Jul 18, 2021 Abandoned
Array ( [id] => 17197986 [patent_doc_number] => 20210338080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => ALZHEIMER'S DISEASE PERSONALIZED MEDICINE [patent_app_type] => utility [patent_app_number] => 17/378487 [patent_app_country] => US [patent_app_date] => 2021-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378487 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/378487
Alzheimer's disease personalized medicine Jul 15, 2021 Issued
Array ( [id] => 17185552 [patent_doc_number] => 20210332437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => METHODS FOR NON-INVASIVE DETECTION OF TRANSPLANT HEALTH OR REJECTION [patent_app_type] => utility [patent_app_number] => 17/370646 [patent_app_country] => US [patent_app_date] => 2021-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370646 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/370646
METHODS FOR NON-INVASIVE DETECTION OF TRANSPLANT HEALTH OR REJECTION Jul 7, 2021 Abandoned
Array ( [id] => 18612757 [patent_doc_number] => 20230279492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT [patent_app_type] => utility [patent_app_number] => 18/014814 [patent_app_country] => US [patent_app_date] => 2021-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014814 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/014814
METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT Jul 4, 2021 Pending
Array ( [id] => 19332882 [patent_doc_number] => 20240247312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT [patent_app_type] => utility [patent_app_number] => 18/014801 [patent_app_country] => US [patent_app_date] => 2021-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64999 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014801 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/014801
METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT Jul 4, 2021 Pending
Array ( [id] => 17168837 [patent_doc_number] => 20210322507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 17/363897 [patent_app_country] => US [patent_app_date] => 2021-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363897 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/363897
GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS Jun 29, 2021 Pending
Menu